Volastra Therapeutics, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2023-03-13. The offering totals $60.2M, of which $60.2M was reported sold. Industry: Biotechnology.
Showing 25 of 26 people.
| Name | Role | Location |
|---|---|---|
| Amy Schulman | Director | Cambridge, MA |
| Stefan Vitorovic | Director | BOSTON, MA |
| Sandra Peterson | Executive Officer | NEW YORK, NY |
| Michael Su | Executive Officer | New York, NY |
| Diane Tager | Executive Officer | New York, NY |
| Sandra Peterson | Director | NEW YORK, NY |
| Robert Mittendorff | Director | SAN FRANCISCO, CA |
| Jill Goldstein | Director | NEW YORK, NY |
| David Southwell | Director | NEW YORK, NY |
| David Southwell | Executive Officer | NEW YORK, NY |
| Arjun Balar | Director | NEW YORK, NY |
| Samuel Bakhoum | Director | NEW YORK, NY |
| Ellie McGuire | Director | NEW YORK, NY |
| Luc Dochez | Director | NEW YORK, NY |
| David Nicholson | Director | Carlsbad, CA |
| Arjun Zolot Balar | Director | New York, NY |
| Stefan Zolot Vitorovic | Director | New York, NY |
| Eileen Zolot McGuire | Director | New York, NY |
| Rachel Zolot Schwartz | Executive Officer | New York, NY |
| Samuel Zolot Bakhoum | Director | New York, NY |
| Scott Drutman | Executive Officer | New York, NY |
| Charles Hugh-Jones | Director | New York, NY |
| Charles Hugh-Jones | Executive Officer | New York, NY |
| David Zolot Nicholson | Director | New York, NY |
| Sandra Zolot Peterson | Director | New York, NY |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2025-09-23 | D | $30.1M | $30.1M |
| 2024-05-30 | D | $15.0M | $15.0M |